Furthermore, we integrated the FTH1-mediated TfR upregulation mechanism with Tf-modified drug-loaded liposomes (Tf-LPD) for targeted therapy, achieving a unified diagnostic and therapeutic approach for gliomas. The gene discussed is FTH1; the disease is central nervous system cancer.